Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

SELL
$181.39 - $234.03 $370,761 - $478,357
-2,044 Closed
0 $0
Q3 2021

Oct 27, 2021

BUY
$189.29 - $209.69 $19,686 - $21,807
104 Added 5.36%
2,044 $397,000
Q2 2021

Aug 02, 2021

BUY
$155.9 - $187.99 $56,435 - $68,052
362 Added 22.94%
1,940 $362,000
Q1 2021

Apr 19, 2021

BUY
$144.0 - $169.39 $17,280 - $20,326
120 Added 8.23%
1,578 $249,000
Q4 2020

Feb 01, 2021

BUY
$157.07 - $174.35 $18,534 - $20,573
118 Added 8.81%
1,458 $241,000
Q3 2020

Oct 23, 2020

BUY
$137.1 - $165.37 $183,714 - $221,595
1,340 New
1,340 $222,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Peoples Bank Portfolio

Follow Peoples Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank , based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank with notifications on news.